This study reports on an empirically underdocumented practice in contemporary aesthetic enhancement culture, the self-injection of unregulated DIY Botox and dermal filler kits purchased online. Data were collected from 4 online discussion forums containing disclosures in relation to use of DIY kits and analyzed using ethnographic content analysis. Motivation to source DIY Botox and dermal fillers online was grounded in desire to avoid financial cost of professional services and a lack of confidence in practitioners. Future intentions to order online raw materials and “formulas” to prepare dermal fillers at home were expressed. Individuals taught themselves to inject through watching YouTube tutorials and downloading Botox injection maps from the Internet. Although individuals demonstrated awareness of the health risks involved with self-injection of unregulated products, this was not a deterrent. Future research is warranted to document the injecting practices and health outcomes of individuals who inject DIY Botox and dermal filler kits to inform targeted harm reduction interventions by health-care practitioners.
Evans-BrownMJMcVeighJPerkinsCBellisMA. Human Enhancement Drugs: The Emerging Challenges to Public Health. Liverpool, United Kingdom: Centre for Public Health, Liverpool; 2012.
2.
PelzterKPengpidS. Knowledge about, attitude toward, and practice of skin lightening products use and its social correlates among university students in five Association of Southeast Asian Nations (ASEAN) countries. Int J Dermatol. 2017;56(3):277–283.
3.
LarteyMKrampaFAbdul-RahmanM. Use of skin-lightening products among selected urban communities in Accra, Ghana. Int J Dermatol. 2017;56(1):32–39.
4.
Van HoutMC.SMART. An internet study of users experiences of synthetic tanning. Perform Enhance Health. 2014;3(1):3–14.
5.
BrennanRWellsJSVan HoutMC. An unhealthy glow? A review of melanotan use and associated clinical outcomes. Perform Enhance Health. 2015;3(2):78–92.
StensballeAMcVeighJBreindahlTKimergardA. Synthetic growth hormone releasers detected in seized drugs: new trends in the use of drugs for performance enhancement. Addict. 2015;110(2):368–369.
10.
BreindahlTEvans-BrownMHinderssonP. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. Drug Test Anal. 2015;7(2):164–172.
11.
KimergardAMcVeighJKnutssonSBreindahlTStensballeA. Online marketing of synthetic peptide hormones: poor manufacturing, user safety, and challenges to public health. Drug Test Anal. 2014;6(4):396–398.
12.
ChertowDSTanETMaslankaSESchulteJBresnitzEAWeismanRS. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA. 2006;296:2476–2479.
13.
SouayahNKarimHKaminSSMcArdleJMarcusS. Severe botulism after focal injection of botulinum toxin. Neurology. 2006;67(10):1855–1856.
14.
RoweRBergerIYaseenBCopelandJ. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia. Drug Alcohol Rev. 2017;36(5):658–666.
15.
HopeVDMcVeighJMarongiuA. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking. Epidemiol Infect. 2015;143(1):132–140.
16.
HopeVDMcVeighJMarongiuA. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open. 2013;3(9):1–11.
17.
LemperleGDuffyDM. Treatment options for dermal filler complications. Aesthet Surg J. 2006;26:356–364.
18.
UnderwoodM. Exploring the social lives of image and performance enhancing drugs: an online ethnography of the Zyzz fandom of recreational bodybuilders. Int J Drug Policy. 2017;39:78–85.
19.
BarrettMAldridgeJ. Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask). Int J Drug Policy. 2016;35:1–6.
20.
BilgreiOR. From “herbal highs” to the “heroin of cannabis”: Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum. Int J Drug Policy. 2016;29:1–8.
SoussanCKjellgrenA. “Chasing the high”—experiences of ethylphenidate as described on international internet forums. Subst. Abuse. 2015;9, 9–16.
23.
BarrattMJ. Discussing illicit drugs in public internet forums: visibility, stigma, and pseudonymity. Paper presented at: the 5th International Conference on Communities and Technologies, June/July 2011; Brisbane, Australia. https://pdfs.semanticscholar.org/2f59/02c763cf322d0dd1aca248132a212fedb23f.pdf. Accessed March 21, 2018.
24.
KrippendorfK. Content Analysis, an Introduction to its Methodology. 2nd ed. Thousand Oaks, CA: Sage Publications; 2004:413.
25.
AltheideDLSchneiderCJ. Qualitative Media Analysis. 2nd ed. London: SAGE Publishing; 2013.
26.
Peretti-WatelPMoattiJP. Understanding risk behaviours: how the sociology of deviance may contribute? The case of drug taking. Soc Sci Med. 2006;63(3):675–679.
27.
Peretti-WatelP. Neutralization theory and the denial of risk: some evidence from cannabis use among French adolescents. Br J Sociol. 2003;54(1):21–42.
28.
BoysAMarsdenJFountainJGriffithsPStillwellGStrangJ. What influences young people’s use of drugs? A qualitative study of decision making. Drugs (Abingdon Engl). 1999;6(3):373–387.
29.
BerkowitzD. Botox Nation: Changing the Fact of America. New York, NY: NYU Press; 2017.
30.
MertonRK. Social structure and anomie. Am Sociol Rev. 1983;3:672–682.
31.
SykesGMMatzaD. Techniques of neutralization: a theory of delinquency. Am Sociol Rev. 1957;22(6):664–670.
32.
Van HoutMC. Kitchen chemistry: a scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. Drug Test Anal. 2014;6(7-8):778–787.
